PTEN, PIK3CA, p-AKT, and p-p70S6K Status
Francisco J. Esteva(Northwell Health), Dihua Yu(The University of Texas MD Anderson Cancer Center)
Cited by 285
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
|Cancer|2011|291
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
|Journal of Clinical Investigation|2017|231